{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T07:07:21Z","timestamp":1785395241310,"version":"3.55.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.bmcl.2023.129123","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T11:45:58Z","timestamp":1672746358000},"page":"129123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Structure-activity relationship of dibenzylideneacetone analogs against the neglected disease pathogen, Trypanosoma brucei"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9742-8801","authenticated-orcid":false,"given":"Karol R.","family":"Francisco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8468-8073","authenticated-orcid":false,"given":"Ludovica","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6760-3805","authenticated-orcid":false,"given":"Hayoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence J.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1838-9806","authenticated-orcid":false,"given":"Dilini K.","family":"Amarasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Nalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Roberto Polaquini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis O.","family":"Regasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f4nio","family":"Eduardo Miller Crotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2489-0178","authenticated-orcid":false,"given":"Romano","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizandra","family":"Guidi Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor R.","family":"Caffrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2023.129123_b0005","unstructured":"Human African Trypanosomiasis (Sleeping Sickness):The Road to Elimination Revisited\u2014Achievements and Remaining Challenges. Tropical Medicine and Infectious Diseases: MDPI; 2020."},{"key":"10.1016\/j.bmcl.2023.129123_b0010","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.3389\/fmicb.2016.02126","article-title":"An Overview of Trypanosoma brucei Infections: An Intense Host-Parasite Interaction","volume":"7","author":"Ponte-Sucre","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bmcl.2023.129123_b0015","unstructured":"Trypanosomiasis, human African (sleeping sickness); 2022. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/trypanosomiasis-human-african-(sleeping-sickness)."},{"key":"10.1016\/j.bmcl.2023.129123_b0020","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1179\/2047773213Y.0000000105","article-title":"A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis","volume":"107","author":"Babokhov","year":"2013","journal-title":"Pathogens Global Health"},{"key":"10.1016\/j.bmcl.2023.129123_b0025","first-page":"35","article-title":"The detection and treatment of human African trypanosomiasis","volume":"3","author":"Bouteille","year":"2012","journal-title":"Res Rep Trop Med"},{"key":"10.1016\/j.bmcl.2023.129123_b0030","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.pt.2018.04.002","article-title":"Melarsoprol Resistance in African Trypanosomiasis","volume":"34","author":"Fairlamb","year":"2018","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.bmcl.2023.129123_b0035","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.pt.2012.12.005","article-title":"Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story","volume":"29","author":"Baker","year":"2013","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.bmcl.2023.129123_b0040","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2217\/fmb.11.88","article-title":"Drug resistance in human African trypanosomiasis","volume":"6","author":"Barrett","year":"2011","journal-title":"Future Microbiol"},{"key":"10.1016\/j.bmcl.2023.129123_b0045","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1128\/AAC.00332-10","article-title":"Cross-resistance to nitro drugs and implications for treatment of human African trypanosomiasis","volume":"54","author":"Sokolova","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2023.129123_b0050","doi-asserted-by":"crossref","first-page":"e1001204","DOI":"10.1371\/journal.ppat.1001204","article-title":"A molecular mechanism for eflornithine resistance in African trypanosomes","volume":"6","author":"Vincent","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bmcl.2023.129123_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.828111","article-title":"An Update on African Trypanocide Pharmaceutics and Resistance","volume":"9","author":"Kasozi","year":"2022","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.bmcl.2023.129123_b0060","doi-asserted-by":"crossref","first-page":"e999","DOI":"10.1016\/S2214-109X(21)00208-4","article-title":"Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study","volume":"9","author":"Mesu","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.bmcl.2023.129123_b0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/tropicalmed5010029","article-title":"New Drugs for Human African Trypanosomiasis: A Twenty First Century Success Story","volume":"5","author":"Dickie","year":"2020","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.bmcl.2023.129123_b0070","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2217\/fmb.11.44","article-title":"Development of novel drugs for human African trypanosomiasis","volume":"6","author":"Brun","year":"2011","journal-title":"Future Microbiol"},{"key":"10.1016\/j.bmcl.2023.129123_b0075","doi-asserted-by":"crossref","first-page":"20091","DOI":"10.3390\/molecules191220091","article-title":"The chemistry of curcumin: from extraction to therapeutic agent","volume":"19","author":"Priyadarsini","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2023.129123_b0080","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1440-1681.2011.05648.x","article-title":"Discovery of curcumin, a component of golden spice, and its miraculous biological activities","volume":"39","author":"Gupta","year":"2012","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.bmcl.2023.129123_b0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/0972-2327.40220","article-title":"The effect of curcumin (turmeric) on Alzheimer's disease: An overview","volume":"11","author":"Mishra","year":"2008","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.bmcl.2023.129123_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/foods6100092","article-title":"Curcumin: A Review of Its Effects on Human Health","volume":"6","author":"Hewlings","year":"2017","journal-title":"Foods."},{"key":"10.1016\/j.bmcl.2023.129123_b0095","first-page":"17","article-title":"Meriva\u00ae, a lecithinized curcumin delivery system, in the control of benign prostatic hyperplasia: a pilot, product evaluation registry study","volume":"54","author":"Ledda","year":"2012","journal-title":"Panminerva Med"},{"key":"10.1016\/j.bmcl.2023.129123_b0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4161\/cbt.9.1.10392","article-title":"Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer","volume":"9","author":"Bayet-Robert","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.bmcl.2023.129123_b0105","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/1078155211416530","article-title":"Effect of imatinib therapy with and without turmeric powder on nitric oxide levels in chronic myeloid leukemia","volume":"18","author":"Ghalaut","year":"2012","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.bmcl.2023.129123_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051033","article-title":"A Review of Curcumin and Its Derivatives as Anticancer Agents","volume":"20","author":"Tomeh","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmcl.2023.129123_b0115","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1093\/carcin\/bgm123","article-title":"Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism","volume":"28","author":"Sandur","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bmcl.2023.129123_b0120","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biocel.2008.06.010","article-title":"Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases","volume":"41","author":"Aggarwal","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.bmcl.2023.129123_b0125","doi-asserted-by":"crossref","first-page":"e0167135","DOI":"10.1371\/journal.pone.0167135","article-title":"Curcumin Generates Oxidative Stress and Induces Apoptosis in Adult Schistosoma mansoni Worms","volume":"11","author":"de Paula","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bmcl.2023.129123_b0130","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1128\/AAC.01238-06","article-title":"Cytotoxic effect of curcumin on malaria parasite Plasmodium falciparum: inhibition of histone acetylation and generation of reactive oxygen species","volume":"51","author":"Cui","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2023.129123_b0135","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s00436-011-2790-9","article-title":"Curcumin treatment provides protection against Trypanosoma cruzi infection","volume":"110","author":"Nagajyothi","year":"2012","journal-title":"Parasitol Res"},{"key":"10.1016\/j.bmcl.2023.129123_b0140","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.actatropica.2017.04.027","article-title":"Curcumin alters the cytoskeleton and microtubule organization on trophozoites of Giardia lamblia","volume":"172","author":"Guti\u00e9rrez-Guti\u00e9rrez","year":"2017","journal-title":"Acta Trop"},{"key":"10.1016\/j.bmcl.2023.129123_b0145","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/513481a","article-title":"Chemistry: Chemical con artists foil drug discovery","volume":"513","author":"Baell","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2023.129123_b0150","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1021\/acs.jmedchem.5b01009","article-title":"Can Invalid Bioactives Undermine Natural Product-Based Drug Discovery?","volume":"59","author":"Bisson","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2023.129123_b0155","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1021\/acs.jmedchem.6b00975","article-title":"The Essential Medicinal Chemistry of Curcumin","volume":"60","author":"Nelson","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2023.129123_b0160","doi-asserted-by":"crossref","first-page":"7606","DOI":"10.1021\/acs.jafc.5b00244","article-title":"Degradation of Curcumin: From Mechanism to Biological Implications","volume":"63","author":"Schneider","year":"2015","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.bmcl.2023.129123_b0165","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1039\/C4FO00790E","article-title":"Thermal stability, antioxidant, and anti-inflammatory activity of curcumin and its degradation product 4-vinyl guaiacol","volume":"6","author":"Esatbeyoglu","year":"2015","journal-title":"Food Funct"},{"key":"10.1016\/j.bmcl.2023.129123_b0170","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0300-483X(80)90122-5","article-title":"Absorption and tissue distribution of curcumin in rats","volume":"16","author":"Ravindranath","year":"1980","journal-title":"Toxicology"},{"key":"10.1016\/j.bmcl.2023.129123_b0175","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0378-5173(91)90278-V","article-title":"Interaction of Curcumin with Glutathione","volume":"76","author":"Mathews","year":"1991","journal-title":"Int J Pharm"},{"key":"10.1016\/j.bmcl.2023.129123_b0180","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bbrc.2012.10.132","article-title":"The inhibitory effect of curcumin on voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells. cells","volume":"430","author":"Hong","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmcl.2023.129123_b0185","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1021\/jf058146a","article-title":"Metabolism of curcuminoids in tissue slices and subcellular fractions from rat liver","volume":"54","author":"Hoehle","year":"2006","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.bmcl.2023.129123_b0190","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0090-9556(24)15211-7","article-title":"Biotransformation of curcumin through reduction and glucuronidation in mice","volume":"27","author":"Pan","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bmcl.2023.129123_b0195","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1074\/jbc.M110.178806","article-title":"Autoxidative and cyclooxygenase-2 catalyzed transformation of the dietary chemopreventive agent curcumin","volume":"286","author":"Griesser","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2023.129123_b0200","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.bmc.2008.10.044","article-title":"Exploration and synthesis of curcumin analogues with improved structural stability both in vitro and in vivo as cytotoxic agents","volume":"17","author":"Liang","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2023.129123_b0205","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1021\/acs.chemrev.7b00020","article-title":"Chalcone: A Privileged Structure in Medicinal Chemistry","volume":"117","author":"Zhuang","year":"2017","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2023.129123_b0210","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3390\/molecules22081210","article-title":"Chalcone Derivatives: Promising Starting Points for Drug Design","volume":"22","author":"Gomes","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2023.129123_b0215","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.parint.2018.06.004","article-title":"Chemoprevention of Leishmaniasis: In-vitro antiparasitic activity of dibenzalacetone, a synthetic curcumin analog leads to apoptotic cell death in Leishmania donovani","volume":"67","author":"Chauhan","year":"2018","journal-title":"Parasitol Int"},{"key":"10.1016\/j.bmcl.2023.129123_b0220","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1007\/s00436-020-06810-4","article-title":"Antiparasitic dibenzalacetone inhibits the GTPase activity of Rab6 protein of Leishmania donovani (LdRab6), a potential target for its antileishmanial effect","volume":"119","author":"Chauhan","year":"2020","journal-title":"Parasitol Res"},{"key":"10.1016\/j.bmcl.2023.129123_b0225","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.bmc.2013.12.020","article-title":"Unsymmetrical 1,5-diaryl-3-oxo-1,4-pentadienyls and their evaluation as antiparasitic agents","volume":"22","author":"Din","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2023.129123_b0230","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1016\/j.bmcl.2011.03.037","article-title":"Dibenzylideneacetone analogues as novel Plasmodium falciparum inhibitors","volume":"21","author":"Aher","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2023.129123_b0235","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.exppara.2017.02.006","article-title":"Design, in silico and in vitro evaluation of curcumin analogues against Plasmodium falciparum","volume":"175","author":"Dohutia","year":"2017","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.bmcl.2023.129123_b0240","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1007\/s00044-018-2237-2","article-title":"Synthesis, mechanistic and synergy studies of diarylidenecyclohexanone derivatives as new antiplasmodial pharmacophores","volume":"27","author":"Joshi","year":"2018","journal-title":"Med Chem Res"},{"key":"10.1016\/j.bmcl.2023.129123_b0245","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.biopha.2018.12.058","article-title":"Antiparasitic activity of synthetic curcumin monocarbonyl analogues against Trichomonas vaginalis","volume":"111","author":"Carapina da Silva","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmcl.2023.129123_b0250","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1128\/AAC.01360-15","article-title":"Dibenzylideneacetones Are Potent Trypanocidal Compounds That Affect the Trypanosoma cruzi Redox System","volume":"60","author":"Lazarin-Bid\u00f3ia","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2023.129123_b0255","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7254193","article-title":"Effects of (1E,4E)-2-Methyl-1,5-bis(4-nitrophenyl) penta-1,4-dien-3-one on Trypanosoma cruzi and Its Combinational Effect with Benznidazole, Ketoconazole, or Fluconazole","volume":"2017","author":"Peron","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.bmcl.2023.129123_b0260","article-title":"In vitro anti-Trypanosoma cruzi activity enhancement of curcumin by its monoketone tetramethoxy analog diveratralacetone","volume":"1","author":"Souza","year":"2021","journal-title":"Curr Res Parasit Vector-Borne Dis"},{"key":"10.1016\/j.bmcl.2023.129123_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103031","article-title":"Antibacterial activity of 3,3'-dihydroxycurcumin (DHC) is associated with membrane perturbation","volume":"90","author":"Polaquini","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2023.129123_b0270","doi-asserted-by":"crossref","first-page":"e1800216","DOI":"10.1002\/cbdv.201800216","article-title":"Antimicrobial Activity of Monoketone Curcuminoids Against Cariogenic Bacteria","volume":"15","author":"Vieira","year":"2018","journal-title":"Chem Biodivers"},{"key":"10.1016\/j.bmcl.2023.129123_b0275","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.fitote.2017.09.007","article-title":"Effects of curcumin and curcumin analogues on TRP channels","volume":"122","author":"Nalli","year":"2017","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bmcl.2023.129123_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110191","article-title":"EF24, a schistosomicidal curcumin analog: Insights from its synthesis and phenotypic, biochemical and cytotoxic activities","volume":"368","author":"Badoco","year":"2022","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bmcl.2023.129123_b0285","article-title":"Use of glycerol, waste glycerol from biodiesel production and other protic solvents in bioactive alpha, beta-unsaturated ketones synthesis","volume":"16","author":"Torrezan","year":"2020","journal-title":"Sustain Chem Pharm"},{"key":"10.1016\/j.bmcl.2023.129123_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104668","article-title":"Antibacterial activity of a new monocarbonyl analog of curcumin MAC 4 is associated with divisome disruption","volume":"109","author":"Polaquini","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2023.129123_b0295","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/cmdc.201800404","article-title":"Brain-Penetrant Triazolopyrimidine and Phenylpyrimidine Microtubule Stabilizers as Potential Leads to Treat Human African Trypanosomiasis","volume":"13","author":"Monti","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmcl.2023.129123_b0300","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/1087057114556236","article-title":"Drug discovery for human African trypanosomiasis: identification of novel scaffolds by the newly developed HTS SYBR Green assay for Trypanosoma brucei","volume":"20","author":"Faria","year":"2015","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.bmcl.2023.129123_b0305","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1046\/j.1432-1327.2000.01606.x","article-title":"Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity","volume":"267","author":"O'Brien","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bmcl.2023.129123_b0310","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ejmech.2009.11.035","article-title":"Curcuminoid analogs with potent activity against Trypanosoma and Leishmania species","volume":"45","author":"Changtam","year":"2010","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2023.129123_b0315","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1124\/mol.114.096016","article-title":"Potent trypanocidal curcumin analogs bearing a monoenone linker motif act on trypanosoma brucei by forming an adduct with trypanothione","volume":"87","author":"Alkhaldi","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bmcl.2023.129123_b0320","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.2174\/1389557515666160509125243","article-title":"The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis","volume":"16","author":"Ettari","year":"2016","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.bmcl.2023.129123_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.molbiopara.2021.111395","article-title":"Should the enzyme name 'rhodesain' be discontinued?","volume":"245","author":"Steverding","year":"2021","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.bmcl.2023.129123_b0330","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1080\/14786419.2018.1483927","article-title":"Drug combination studies of curcumin and genistein against rhodesain of Trypanosoma brucei rhodesiense","volume":"33","author":"Ettari","year":"2019","journal-title":"Nat Prod Res"},{"key":"10.1016\/j.bmcl.2023.129123_b0335","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/BF02977357","article-title":"Structural requirements of 2 ',4 ',6 '-tris(methoxymethoxy) chalcone derivatives for anti-inflammatory activity: The importance of a 2 '-hydroxy moiety","volume":"30","author":"Jin","year":"2007","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.bmcl.2023.129123_b0340","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pt.2014.04.003","article-title":"Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects","volume":"30","author":"Patterson","year":"2014","journal-title":"Trends Parasitol"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2300001X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2300001X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:46:48Z","timestamp":1760773608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X2300001X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":68,"alternative-id":["S0960894X2300001X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2023.129123","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-activity relationship of dibenzylideneacetone analogs against the neglected disease pathogen, Trypanosoma brucei","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2023.129123","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"129123"}}